{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-062095","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.327702+00:00","generated_at":"2026-05-18T22:42:45.121357+00:00","sec_items":["1.01","5.03","2.03","3.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Eyenovia raises $50M to acquire HYPE tokens, shifts to crypto treasury strategy; appoints new CIO","bullets":["$50M PIPE for HYPE tokens; warrants could raise ~$150M more if exercised at $3.25/share.","Hyunsu Jung appointed CIO and board member; three directors resigned per investor agreement.","Loan amended: maturity extended to July 2028, interest rate cut to 8% (half PIK), interest-only through Jan 2027.","Company expects to rename to Hyperion DeFi and change ticker to HYPD.","Gen-2 Optejet device still in development; FDA registration anticipated by September 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-062095","json":"https://secwatch.observer/filing/0001104659-25-062095.json","markdown":"https://secwatch.observer/filing/0001104659-25-062095.md","text":"https://secwatch.observer/filing/0001104659-25-062095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/tm2518559d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:42:45.121357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17a0370c36","claim":"Sean Ianchulev resigned as Director at HYPERION DEFI, INC..","evidence_excerpt":"On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3681ba5c1f","claim":"Hyunsu Jung was appointed as Chief Investment Officer at HYPERION DEFI, INC..","evidence_excerpt":"On June 17, 2025, the Board of Directors (the “Board”) of the Company appointed Hyunsu Jung to the position of Chief Investment Officer and to serve on the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Investment Officer"}],"fact_type":"executive_change"},{"claim_id":"520d9114a3","claim":"Ram Palanki resigned as Director at HYPERION DEFI, INC..","evidence_excerpt":"On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"db6aaf12aa","claim":"Charles Mather IV resigned as Chair at HYPERION DEFI, INC..","evidence_excerpt":"On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chair"}],"fact_type":"executive_change"},{"claim_id":"3ca77413f6cb1a48e040891f41bd1ce321acda26","claim":"HYPERION DEFI, INC.: Filed Certificate of Designation for Series A Preferred Stock, establishing terms of a new series of preferred stock (effective 2025-06-20).","evidence_excerpt":"On June 20, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware to provide for the designation of shares of the Series A Preferred Stock (the \"Certificate of Designation\"), which became effective upon filing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925062095/0001104659-25-062095-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}